|
| 37612291 | Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5. | | 2023 |
| 30559381 | Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. | Nature | 2019 |
| 27986745 | Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma. | Clin Cancer Res | 2017 |
| 28153829 | Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling. | Annals of the Rheumatic Diseases | 2017 |
| 28042617 | Temporary, Systemic Inhibition of the WNT/β-Catenin Pathway promotes Regenerative Cardiac Repair following Myocardial Infarct. | Cell Stem Cells Regen Med | 2016 |
| 27251290 | Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors. | Nature | 2016 |
| 27437076 | Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors. | ACS Medicinal Chemistry Letters | 2016 |
| 26825170 | EGF816 Exerts Anticancer Effects in Non-Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor. | Cancer Research | 2016 |
| 27117272 | In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model. | J Otolaryngol Head Neck Surg | 2016 |
| 26005534 | (R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors. | ACS Med Chem Lett | 2015 |
| 24675041 | The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer. | Cancer Discovery | 2014 |
| 25495526 | Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening. | BMC Cancer | 2014 |
| 23392674 | Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in mice. | Journal of Neuroscience | 2013 |
| 23742252 | Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials. | J Med Chem | 2013 |
| 24277854 | Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. | Proc Natl Acad Sci U S A | 2013 |
| 22460905 | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. | Nature | 2012 |
| 21704013 | Cloning, expression, and enzymatic activity of Acinetobacter baumannii and Klebsiella pneumoniae acetyl-coenzyme A carboxylases. | Analytical Biochemistry | 2011 |
| 20015050 | Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA. | Biochemical Journal | 2010 |
| 21107320 | COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. | Nature | 2010 |
| 20133595 | Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency. | Proc Natl Acad Sci U S A | 2010 |
| 20045465 | Transient expression of an IL-23R extracellular domain Fc fusion protein in CHO vs. HEK cells results in improved plasma exposure. | Protein Expression and Purification | 2010 |
| 20632993 | Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain. | Biochem J | 2010 |
| 18313933 | Substrate optimization for monitoring cathepsin C activity in live cells. | Bioorganic and Medicinal Chemistry | 2009 |
| 19388054 | Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations. | Protein Sci | 2009 |
| 19426707 | TAF15 and the leukemia-associated fusion protein TAF15-CIZ/NMP4 are cleaved by caspases-3 and -7. | Biochemical and Biophysical Research Communications | 2009 |
| 18752942 | Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design. | Bioorganic and Medicinal Chemistry Letters | 2008 |
| 17382545 | Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S. | Bioorganic and Medicinal Chemistry Letters | 2007 |
| 17710090 | Small molecules not direct activators of caspases. | Nature Chemical Biology | 2007 |
| 17608623 | Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity. | Biochem J | 2007 |
| 17804797 | The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain. | Proc Natl Acad Sci U S A | 2007 |
| 17976015 | Defining the extended substrate specificity of kallikrein 1-related peptidases. | Biol Chem | 2007 |
| 17196818 | Bicyclic carbamates as inhibitors of papain-like cathepsin proteases. | Bioorganic and Medicinal Chemistry Letters | 2007 |
| 16876402 | Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers. | Bioorganic and Medicinal Chemistry Letters | 2006 |
| 17028019 | Serpin1 of Arabidopsis thaliana is a suicide inhibitor for metacaspase 9. | Journal of Molecular Biology | 2006 |
| 16412634 | Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl. | Bioorganic and Medicinal Chemistry Letters | 2006 |
| 17009273 | Self-assembled small-molecule microarrays for protease screening and profiling. | ChemBioChem | 2006 |
| 16798735 | Granzyme B proteolyzes receptors important to proliferation and survival, tipping the balance toward apoptosis. | J Biol Chem | 2006 |
| 16446091 | Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3. | Bioorganic and Medicinal Chemistry Letters | 2006 |
| 16876407 | Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors. | Bioorganic and Medicinal Chemistry Letters | 2006 |
| 16307522 | Microarray-based functional protein profiling using peptide nucleic acid-encoded libraries. | Expert Review of Proteomics | 2005 |
| 16038006 | PNA encoding (PNA=peptide nucleic acid): from solution-based libraries to organized microarrays. | Chemistry - A European Journal | 2005 |
| 15932883 | Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. | Journal of Biological Chemistry | 2005 |
| 15878267 | A strategy to profile prime and non-prime proteolytic substrate specificity. | Bioorganic and Medicinal Chemistry Letters | 2005 |
| 16183279 | Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1. | Bioorganic and Medicinal Chemistry Letters | 2005 |
| 15157086 | Substrate profiling of deubiquitin hydrolases with a positional scanning library and mass spectrometry. | Biochemistry | 2004 |
| 15489163 | Activity profile of dust mite allergen extract using substrate libraries and functional proteomic microarrays. | | 2004 |
| 15489162 | PNA-encoded protease substrate microarrays. | | 2004 |
| 15474520 | Biochemical characterization of prostasin, a channel activating protease. | Biochemical and Biophysical Research Communications | 2004 |
| 12819769 | The oligomeric structure of human granzyme A is a determinant of its extended substrate specificity. | Nat Struct Biol | 2003 |
| 12600991 | Biochemical analysis of the 20 S proteasome of Trypanosoma brucei. | J Biol Chem | 2003 |